Infusion therapies, into prescriber practices and infusion centers.
Infusion is a multi-channel sale: the prescriber, the infusion center, the specialty pharmacy, and the patient hub all matter. Solara reps coordinate across all four.
Why infusion needs cross-channel coordination
An infusion drug fails to convert when any link in the chain breaks: the physician decides not to write, the infusion center declines to stock, the specialty pharmacy can't dispense fast enough, or the patient drops off at access. A rep who only handles one link of the chain doesn't move the number. Solara reps work the whole chain.
What changes when infusion runs on the Solara network.
Multi-channel call coverage
Reps call on prescribing practices, infusion centers, and specialty pharmacies in the same territory. The patient pathway is treated as one account, not three.
Buy-and-bill and white-bag fluency
Reps are trained on buy-and-bill economics, white-bagging vs brown-bagging vs clear-bagging policies, payer mandates, and how each model affects practice cash flow.
Home-infusion routing
Where home-infusion is the channel, reps coordinate with home-infusion providers and route enrollment friction back to the manufacturer hub.
Specialties served by this category.
- ·Rheumatology
- ·Gastroenterology
- ·Neurology
- ·Allergy and immunology
- ·Oncology and hematology
- ·Hospital infusion centers
Who Solara distributes for in this category.
- ·Biologics and infused biologics
- ·Antibody-drug conjugates and oncology infusions
- ·Immunoglobulins (IVIG, SCIG)
- ·Iron, biosimilars, and supportive care
- ·Home-infusion-distributed therapies
What manufacturers ask before they pilot.
- Does Solara handle buy-and-bill and white-bag products?
- Yes. Reps are trained on the economics and workflow of each channel — buy-and-bill, white-bag, brown-bag, clear-bag — and on payer mandates that constrain channel choice in different markets.
- Can Solara support home-infusion drug launches?
- Yes. Reps coordinate with home-infusion providers and route enrollment friction back to the manufacturer hub. Home-infusion-distributed therapies typically have higher patient-side drop-off than office-administered, so the field-side data feed matters more.
- How does Solara handle hub services and copay assistance?
- Reps facilitate hand-off to the manufacturer hub or specialty pharmacy. Patient enrollment and copay assistance remain with the manufacturer's hub provider; Solara's role is to make sure the hand-off happens and to flag where it stalls.
- Are infusion-rep calls compliant with FDA promotional rules?
- Yes. Promotional materials are platform-controlled and reviewed by manufacturer regulatory before deployment. Reps work only from approved label and approved messaging.
Pilot a infusion territory in 30 days.
Book a working session — we’ll load your target sub-segment into Solara live, walk through territory coverage, and propose a pilot scope.